A HERITAGE OF INNOVATION AND LEADERSHIP

Lantheus Medical Imaging, a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease.

Our proven success in discovering, developing and commercializing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. Lantheus has a rich heritage and expertise in cardiovascular imaging and nuclear medicine, having pioneered many of the most significant products used in medical imaging.

Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We also have a full clinical and preclinical development pipeline of next-generation and first-in-class products using Positron Emission Tomography (PET) and MRI technologies.

Our vision is to be the leading provider of innovative medical imaging solutions to improve human life. We are committed to developing next generation and first-in-class imaging agents to assist physicians in the diagnosis of heart, vascular and other diseases.

With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.

Investor Relations
Quarterly SEC Filings

Recent News

06/12/13
Lantheus Medical Imaging to Present at Wells Fargo Securities 2013 Healthcare Conference

05/29/13
Lantheus Medical Imaging to Present at Jefferies 2013 Global Healthcare Conference

05/07/13
Lantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 p.m. Eastern Time

05/01/13
Lantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study

Company Spotlight

	Webcast Wells Fargo Securities 2013 Healthcare Conference Wednesday, June 19 at 2:25 p.m. ET
	Archived Webcast Jefferies 2013 Global Healthcare Conference Wednesday, June 5 at 1:30 p.m. ET
	Archived Webcast Q1 2013 Lantheus Medical Earnings Conference Call Tuesday, May 14, 2013 at 4:00 p.m. ET

N. Billerica, Mass., June 12, 2013 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Jeff Bailey, President and Chief Executive Officer, will present at the Wells Fargo Securities 2013 Healthcare Conference in Boston. The presentation will take place on Wednesday, June 19, 2013, at 2:25 p.m., Eastern Time.  Mr. Bailey will provide a Company overview and business update.

click here for the press release